Effects of fibrates on the glycine conjugation of benzoic acid in rats

Drug Metabolism and Disposition

Volumn 26, Issue 11, 1998, Pages 1082-1088

  Gregus, Zoltán ^a   Fekete, Tibor ^b   Halászi, Éva ^b   Gyurasics, Ágnes ^b   Klaassen, Curtis D ^b  

^a UNIVERSITY OF PÉCS   (Hungary)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZOIC ACID; BEZAFIBRATE; FENOFIBRATE; FIBRIC ACID DERIVATIVE; GLYCINE; HIPPURIC ACID; LONG CHAIN FATTY ACID COENZYME A LIGASE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG CONJUGATION; DRUG EFFECT; DRUG SCREENING; HEPATOMEGALY; LIVER METABOLISM; LIVER MITOCHONDRION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ANIMAL FEED; ANIMALS; BENZOIC ACID; BEZAFIBRATE; GLYCINE; INJECTIONS, INTRAPERITONEAL; LIVER; MALE; PROCETOFEN; RATS; RATS, WISTAR;

ANIMALIA;

EID: 0031739604     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Bachmann C, Lühti H, Gradwohl M and Colombo JP (1986) Brain uptake of tryptophan in urease-injected hyperammonemic rats after treatment with benzoate or hippurate. Biochem Med Metab Biol 36:214-219.
2. Barr J, Weir AJ, Brendel K and Sipes IG (1991) Liver slices in dynamic organ culture. I. An alternative in vitro technique for the study of rat hepatic drug metabolism. Xenobiotica 21:331-339.
3. Berge RK, Aarsland A, Bakke OM and Farstad M (1983) Hepatic enzymes, CoASH and long-chain acyl-CoA in subcellular fractions as affected by drugs inducing peroxisomes and smooth endoplasmic reticulum. Int J Biochem 15:191-204.
4. Berge RG, Flatmark T and Osmundsen H (1984) Enhancement of long-chain acyl-CoA hydrolase activity in peroxisomes and mitochondria of rat liver by peroxisomal proliferators. Eur J Biochem 141:637-644.
5. Brass EP and Ruff LJ (1992) Rat hepatic coenzyme A is redistributed in response to mitochondrial acyl-coenzyme A accumulation. J Nutr 122:2094-2100.
6. Bridges JW, French MR, Smith RL and Williams RT (1970) The fate of benzoic acid in various species. Biochem J 118:47-51.
7. Caldwell J (1989) The biochemical pharmacology of fenofibrate. Cardiology 76(Suppl 1):33-34.
8. Cyr DM, Egan SG, Brini CM and Tremblay GC (1991) On the mechanism of inhibition of gluconeogenesis and ureagenesis by sodium benzoate. Biochem Pharmacol 42:645-654.
9. Dills RL and Klaassen CD (1985) An isocratic reverse phase high-performance liquid chromatographic assay for adenine nucleotides in rat liver. J Pharmacol Methods 14:189-197.
10. Fürst P, Pollack L, Graser TA, Godel H and Stehle P (1990) Appraisal of four precolumn derivatization methods for the high-performance liquid chromatographic determination of free amino acids in biological materials. J Chromatogr 499:557-569.
11. Garland PB, Yates DW and Haddock BS (1970) Spectrophotometric studies of acyl-coenzyme A synthetases of rat liver mitochondria. Biochem J 119:553-564.
12. Gatley SJ and Sherratt HSA (1977) The synthesis of hippurate from benzoate and glycine by rat liver mitochondria: submitochondrial localization and kinetics. Biochem J 166:39-47.
13. Gornall AG, Bardawill CJ and David MM (1949) Determination of serum proteins by means of biuret reaction. J Biol Chem 177:751-766.
14. Gregus Z, Fekete T, Halászi É and Klaassen CD (1996) Lipoic acid impairs glycine conjugation of benzoic acid and renal excretion of benzoylglycine. Drug Metab Dispos 6:682-688.
15. Gregus Z, Fekete T, Varga F and Klaassen CD (1992) Availability of glycine and coenzyme A limits glycine conjugation in vivo. Drug Metab Dispos 20:234-240.
16. Gregus Z, Fekete T, Varga F and Klaassen CD (1993a) Effect of valproic acid on glycine onjugation of benzoic acid. J Pharmacol Exp Ther 267:1068-1075.
17. Gregus Z, Fekete T, Varga F and Klaassen CD (1993b) Dependence of glycine conjugation on the availability of glycine: the role of the glycine cleavage system. Xenobiotica 23:141-154.
18. Halvorsen O (1983) Effects of hypolipidemic drugs on hepatic CoA. Biochem Pharmacol 62:1126-1128.
19. Hutt AJ and Caldwell J (1990) Amino acid conjugation, in Conjugation Reactions in Drug Metabolism (Mulder GJ ed) pp 273-305, Taylor and Francis, London.
20. Kasuya F, Igarashi K and Fukui M (1996) Inhibition of a medium chain acyl-CoA synthetase involved in glycine conjugation by carboxylic acids. Biochem Pharmacol 52:1643-1646.
21. Levy G (1965) Pharmacokinetics of salicylate elimination in man. J Pharm Sci 54:959-967.
22. Lock EA, Mitchell AM and Elcombe CR (1989) Biochemical mechanisms of induction of hepatic peroxisome proliferation. Annu Rev Pharmacol Toxicol 29:145-163.
23. Meijer J, Starkerud C, Granell I and Afzelius BA (1991) Time-dependent effects of the hypolipidemic agent clofibrate on peroxisomes and mitochondria in mouse hepatocytes. J Submicrosc Cytol Pathol 23:185-194.
24. Michal G and Bergmeyer HU (1974) Determination of CoA-SH with phosphotransacetylase, in Methods in Enzymatic Analysis (Bergmeyer HU ed) pp 1975-1981, Academic Press, New York.
25. Miyazawa S, Sakurai T, Imura M and Hashimoto T (1975) Effects of ethyl p-chlorophenoxyisobutyrate on carbohydrate and fatty acid metabolism in rat liver. J Biochem (Tokyo) 78:1171-1176.
26. Moody DE, Gibson GG, Grant DF, Magdalou J and Rao MS (1992) Peroxisome proliferators, a unique set of drug-metabolizing enzyme inducers: commentary on a symposium. Drug Metab Dispos 6:779-791.
27. Motojima K, Peters JM and Gonzalez FJ (1997) PPARa mediates peroxisome proliferator-induced transcriptional repression of nonperoxisomal gene expression in mouse. Biochem Biophys Res Commun 230:155-158.
28. Paul HS, Gleditsch CE and Adibi SA (1986) Mechanism of increased hepatic concentration of carnitine by clofibrate. Am J Physiol 251:E311-E315.
29. Pearson DJ, Tubbs K and Chase JFA (1974) Carnitine and acylcarnitines, in Methods in Enzymatic Analysis (Bergmeyer HU ed) pp 1758-1771. Academic Press, New York.
30. Saller CF and Czupryna MJ (1989) γ-Aminobutyric acid, glutamate, glycine and taurine analysis using reversed-phase high-performance liquid chromatography and ultraviolet detection of dansyl chloride derivatives. J Chromatogr 487:167-172.
31. Savolainen MJ, Jauhonen VP and Hassinen IE (1977) Effect of clofibrate on ethanol-induced modification in liver and adipose tissue metabolism: role of hepatic redox state and hormonal mechanism. Biochem Pharmacol 26:425-431.
32. Schoonjans K, Genevieve M, Bart S and Auwerx J (1997) Peroxisome proliferator-activated receptors, orphans with ligands and functions. Curr Opin Lipidol 8:159-166.
33. Skrede S and Halvorsen O (1979) Increased biosynthesis of CoA in the liver of rats treated with clofibrate. Eur J Biochem 98:223-229.
34. Tanaka K and Isselbacher K (1967) The isolation and identification of N-isovalerylglycine from urine of patients with isovaleric acidemia. J Biol Chem 242:2966-2972.
35. Tremblay GC and Qureshi IA (1993) The biochemistry and toxicology of benzoic acid metabolism and its relationship to the elimination of waste nitrogen. Pharmacol Ther 60:63-90.
36. Urrea R and Bronfman M (1996) Species differences in the intracellular distribution of ciprofibroyl-CoA hydrolase: implications for peroxisome proliferation. FEBS Lett 389:219-223.
37. Voltti H, Savolainen MJ, Jauhonen VP and Hassinen IE (1979) Clofibrate-induced increase in coenzyme A concentration in rat tissues. Biochem J 182:95-102.
38. Webster L (1981) Benzoyl-CoA:amino acid and phenylacetyl-CoA:amino acid N-acyltransferases. Methods Enzymol 77:301-308.